<SEC-DOCUMENT>0001213900-21-039600.txt : 20211019
<SEC-HEADER>0001213900-21-039600.hdr.sgml : 20211019
<ACCEPTANCE-DATETIME>20210730170122
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-21-039600
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbe Robotics Ltd.
		CENTRAL INDEX KEY:			0001861841
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
		BUSINESS PHONE:		972.73.7969804

	MAIL ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%"><IMG SRC="img_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 30%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DLA Piper LLP (US)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1251 Avenue of the Americas</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">27th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10020-1104</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.dlapiper.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jon Venick</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jon.Venick@dlapiper.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T 212.335.4651</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">F 917.778.8651</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021 &nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Technology</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549-6010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 49.5pt"><B>Attention:</B></TD><TD><B>Brittany Ebertt<BR>
Christine Dietz<BR>
Jan Woo<BR>
Matthew Crispino</B></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">Re:</TD><TD>Arbe Robotics Ltd.<BR>
Registration Statement on Form F-4<BR>
Filed June 21, 2021<BR>
File No. 333-257250</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dear Mr. Crispino:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On behalf of Arbe Robotics Ltd. (the &ldquo;<U>Company</U>&rdquo;),
set forth below are the Company&rsquo;s responses to the comments of the Staff (the &ldquo;<U>Staff</U>&rdquo;) of the Division of Corporation
Finance of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) relating to the Company&rsquo;s Registration Statement
on Form F-4 (the &ldquo;<U>Registration Statement</U>&rdquo;). An electronic version of the amended Registration Statement (&ldquo;<U>Amendment
No. 1</U>&rdquo;) has been concurrently submitted with the Commission through its EDGAR system. The enclosed copy of Amendment No. 1 to
the Registration Statement has been marked to reflect changes made to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Set forth below are the responses of the Company
to the comments of the Staff&rsquo;s letter to the Company, dated July 21, 2021, relating to the Registration Statement. For convenience
of reference, the text of the comments in the Staff&rsquo;s letter has been reproduced in bold and italics herein. The Company has also
provided its response immediately after each numbered comment. We have included page numbers to refer to the location in Amendment No.
1 where the amended language addressing a particular comment appears. Capitalized terms used but not otherwise defined herein have the
meanings assigned to such terms in Amendment No. 1 to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Questions and Answers about the Proposals, page 10</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><I>Please add a Q&amp;A that discloses all possible sources and extent of dilution that shareholders who elect not to redeem their
shares may experience in connection with the business combination. Provide disclosure of the impact of each significant source of dilution,
including the amount of equity held by founders, convertible securities, including warrants retained by redeeming shareholders, at different
redemption levels</I></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company has added
a question and answer on page 21 to disclose fully-diluted stock ownership information based on different levels of redemption. Since
all ITAC warrants remain outstanding, regardless of whether the holder redeemed the common stock, there is no change in the number shares
issued upon exercise of ITAC warrants at the various redemption levels.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="img_001.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Page Two</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>What will be the relative equity stakes of ITAC's public stockholders...,
page 13</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>2.</I></B></TD><TD STYLE="text-align: justify"><B><I>You disclose the equity stake of stockholder groups assuming no redemption by ITAC public stockholders. Please revise to also
disclose the equity stake of these groups assuming maximum redemption by public stockholders.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement to reflect maximum redemption. Please see page 13 of Amendment
No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>I am an ITAC warrant holder. Why am I receiving this proxy statement/prospectus?,
page 17</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><I>Please clarify whether public shareholders
                                            that redeem their shares will retain any warrants. If so, quantify the value of warrants,
                                            based on recent trading prices, that may be retained by redeeming stockholders assuming maximum
                                            redemptions and identify any material resulting risks.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company has added
a risk factor &ldquo;Although holders of ITAC Common Stock who own ITAC Warrants will receive Arbe Warrants if they redeem their ITAC
Common Stock, there are risks attendant to the ownership of the Arbe Warrants&rdquo;. Please see page 65 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Interests of ITAC&rsquo;s Officers and Directors in the Merger,
page 26</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><I>Please disclose if the sponsor and the
                                            company&rsquo;s officers and directors have any fiduciary or contractual obligations to other
                                            entities as well as any interest in, or affiliation with, the target company. If so, clarify
                                            how the board considered such conflicts in negotiating and recommending the business combination.
                                            Also, we note ITAC's charter waived the corporate opportunities doctrine. Please address
                                            this potential conflict of interest and whether it impacted ITAC's search for an acquisition
                                            target.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Sponsor and ITAC&rsquo;s
officers and directors do not have any fiduciary or contractual obligations to other entities, except that, as disclosed in the Registration
Statement under the caption &ldquo;Interests of ITAC&rsquo;s Officers and Directors in the Merger,&rdquo; ITAC&rsquo;s officers, E. Scott
Crist, who is Chief Executive Officer, chairman and a director, and R. Greg Smith, the Chief Financial Officer, hold the same positions
with, and the other three directors are nominees for director of, Industrial Tech Acquisitions II, Inc., which has filed a Registration
Statement for an initial public offering which, as of the date of this letter, has not been declared effective by the Commission. No officer
or director of ITAC has any fiduciary or contractual obligation to or any interest in the Company. Article X of ITAC&rsquo;s current certificate
of incorporation provides that, to the extent permitted by law, the doctrine of corporate opportunity does not apply to the ITAC or any
of its officers and directors. However, all of the activities relating to the search for an acquisition candidate were conducted on behalf
of ITAC with a view to entering into a business combination agreement with a company that the directors thought would bring value to its
stockholders. Please see page 99 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B><IMG SRC="img_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Page Three</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Agreements entered into in connection with the Business Combination
Agreement</U><BR>
<U>PIPE Subscription Agreements, page 28</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>5.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please highlight any material differences in the terms and price of securities issued at the time of the IPO as compared to
the PIPE investment. Disclose if the PIPE investors include ITAC's sponsor, directors, officers or their affiliates. </I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company has added
language describing the relationship between the price paid by the PIPE Investors and both the IPO price and the per share value of the
Arbe Ordinary Shares in the Merger under &ldquo;PIPE Subscription Agreements&rdquo; on page 121 and under &ldquo;PIPE&rdquo; on page 192.
The disclosure also states that entities affiliated with the Sponsor and the Company&rsquo;s chief executive officers are investors in
the PIPE financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Historical Comparative and Pro Forma Combined Per Share Data
of ITAC and Arbe, page 36</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B><I>We note you include a reference to a footnote (3) in your table; however, there does not appear to be a footnote (3) disclosed.
Please revise or advise.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has deleted the footnote reference from the Registration Statement. Please see page 38 of Amendment No.
1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risk Factors</U><BR>
<U>Arbe relies on third-party suppliers..., page 48</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B><I>You disclose on page F-8 that you depend on a certain supplier for the development and production of your products. Please identify
your supplier and disclose the material terms of your agreements with it. Also, file any contracts with the supplier as exhibits or tell
us why this is not required.<SUP>2</SUP></I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The supplier referred
to in the financial statements is Global Foundries, which is a major semiconductor manufacturer. Consistent with industry practice, the
Company does not have an agreement with Global Foundries for the manufacturing of development stage wafers and purchases silicon wafers
pursuant to purchase orders. The Company has expanded the risk factor &ldquo;Arbe relies on third-party suppliers and, because some of
the key components in its products come from limited or sole sources of supply, Arbe is susceptible to supply shortages, long lead times
for components and supply changes, any of which could disrupt its supply chain and could delay deliveries of its products to customers.&rdquo;
to include language to refer to this supplier and to reflect the specific risks attendant to reliance on a sole supplier for semiconductors.
Disclosure of Global Foundries is included in the section &ldquo;Business of Arbe &ndash; Manufacturing.&rdquo; Please see pages 50
and 169 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B><IMG SRC="img_001.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Four</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Relating to the Business Combination, page 61</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B><I>Please add a risk factor that discusses the material risks to unaffiliated investors presented by taking the company public
through a merger rather than an underwritten offering. These risks could include the absence of due diligence conducted by an underwriter
that would be subject to liability for any material misstatements or omissions in a registration statement</I></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and added a risk factor &ldquo;By entering into a business combination with ITAC, which is a SPAC, investors
may not have the same benefits as an investor in an underwritten public offering.&rdquo; Please see page Please see page 67 of Amendment
No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>The Sponsor has a different economic interest in the completion
of the Merger than the Public Stockholders, page 73</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B><I>Please disclose if the sponsor and its affiliates can earn a positive rate of return on their investment, even if other SPAC
shareholders experience a negative rate of return in the post-business combination company.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has added a risk factor &ldquo;The sponsor and its affiliates can earn a positive rate of return on their
investment, even if other SPAC shareholders experience a negative rate of return in the post-business combination company.&rdquo; Please
see page 65 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Certain Unaudited Prospective Financial Information of Arbe</U><BR>
<U>Satisfaction of the 80% Test, page 96</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B><I>Please describe how the ITAC board arrived at its valuation for Arbe, including a description of any financial models or analyses
the board considered.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company has included
language under &ldquo;The ITAC Board of Directors&rsquo; Reasons for the Merger&rdquo; to include more specific disclosure relating to
ITAC&rsquo;s evaluation of the Company. Please see page 96 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B><IMG SRC="img_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Five</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>U.S. Federal Income Tax Considerations of the Merger, page 121</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>11.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note that the parties &quot;intend&quot; for the business combination to be a reorganization within the meaning of Section
368(a) of the Tax Code. However, the disclosure does not indicate whether the parties expect the business combination to be tax-free (with
respect to the receipt of stock) to U.S. holders. Revise to make clear whether the parties expect the business combination to be tax-free
to U.S. holders. If you are unable to conclude that the business combination is likely to be tax-free, revise your risk factor relating
to the material tax consequences of the business combination (page 63) to focus on the uncertainty and the consequences of the business
combination being taxable to U.S. holders. If you are able to conclude that the business combination is likely to be tax-free to U.S.
holders, include a tax opinion supporting such a conclusion. For further guidance see Staff Legal Bulletin No. 19 (October 14, 2011) and
Item 601(b)(8) of Regulation S-K.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: ITAC and the Company,
after consultation with their respective tax counsel, do not believe they can conclude that the business combination is likely to be tax-free
to US Holders of ITAC Common Stock. They have, however, in response to the comments from the Commission, made revisions to the US tax
disclosure to reflect the uncertainty and the consequences if the business combination is determined not to qualify as a tax-free reorganization.
Please see page 126 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Unaudited Pro Forma Condensed Combined Financial Information,
page 186</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>12.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note the number of pro forma shares outstanding under each scenario as shown in the table on page 188 does not agree to the
number of pro forma shares disclosed in the footnotes to your pro forma balance sheets on pages 190 and 192, respectively. Please revise
or advise.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The total number of shares
being issued to existing Arbe shareholders in the table on page 193 reflects the number of Arbe Ordinary Shares that will be outstanding
at the Closing, after giving effect (i) to the Recapitalization and (ii) the issuance of shares subsequent to December 31, 2020 that are
not related to the Merger. As described in the F-4, pursuant to the Recapitalization, (s) all outstanding warrants will be exercised (other
than those warrant are designed in the F-4 as Continuing Arbe Warrants) and upon such exercise, ordinary and preferred shares will be
issued, (ii) all preferred shares will be converted into ordinary shares in accordance with the terms of the preferred shares, and (iii)
the ordinary shares will be recapitalized, based upon the agreed upon valuation and a $10.00 price per Arbe Ordinary Share. Using this
computation, the existing Arbe shareholders will hold 48,275,832 ordinary shares, and the total ordinary shares outstanding at Closing
is 67,956,568 assuming no redemption and 60,332,968 assuming maximum redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The pro forma financial statements reflect
the capitalization as of December 31, 2020 assuming no redemption and assuming maximum redemption. The number of ordinary shares at December
31, 2020, on a pro forma basis, are 64,643,935 assuming no redemption and 57,020,335 assuming maximum reduction. In each case, the difference
between the numbers on page 193 and the numbers on pages 195 and 197 is 3,312,633 ordinary shares. In preparing the pro forma financial
statements, the Company started with the shares outstanding at December 31, 2020 and adjusted that number to reflect shares that are issued
in connection with the Merger, such as the PIPE investment. The pro forma financial statements do not (and should not) reflect stock issuances
subsequent to December 31, 2020 that are not related to the business combination but were issued subsequent to the balance sheet date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="img_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Six</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the information of the staff, the
3,312,633 shares reflect, primarily, funds raised in January 2021 as the last installment pursuant to an investment agreement that was
entered into in the first quarter of 2021 and is described in Note 15(a) of Arbe&rsquo;s financial statements representing shares issuable
prior to the closing, and, to a lesser extent, warrants that were issued in 2021 and the exercise of employee stock options in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Since the pro forma balance sheets
on pages 194 and 196 relate to the December 31, 2020 balance sheet, the pro forma adjustment relate to adjustments to that balance
sheet and the number of Arbe shares outstanding on such date. The table on page 193 is a snapshot of the outstanding ordinary
shares at the Closing and reflects the 3,312,633 ordinary shares issued subsequent to December 31, 2020 in transactions not related
to the business combination. Thus, the numbers are different because they present different information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>13.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note you do not reflect any par value for the pro forma common stock to be outstanding subsequent to the transactions. Additionally,
we note the entire amount of $100M from the issuance of shares to the PIPE investors is reflected within additional paid-in capital per
pro forma adjustment (J). Please tell us why there is no par value reflected in the pro forma common stock line item for the shares to
be issued and outstanding subsequent to the transactions, or revise accordingly.</I></B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see pages 190, 192 and 196 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>14.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note that Pro Forma Loss per Share on page 197 has been adjusted to reflect the exercise of 19,804 warrants into Arbe Ordinary
Shares. However, there do not appear to be any adjustments to the pro forma financial statements for this transaction. Please advise.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see pages 195, 196 and 201 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>3. Adjustments to Unaudited Pro Forma Condensed Combined Financial
Information, page 195</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>15.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note your references to including adjustments that are directly attributable to the Transactions, factually supportable and
expected to have a continuing impact. Please revise your disclosures to comply with the updated guidance in Article 11-02 of Regulation
S-X.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see page 200 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B><IMG SRC="img_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Seven</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Beneficial Ownership of Arbe Securities, page 209</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>16.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please disclose the portion of each class of Arbe securities held in the United States and the number of record holders in the
United States. Refer to Item 18 of Form F-4 and Item 7.A.2 of Form 20-F.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement to include information as to United States shareholders under &ldquo;Price
Range of Securities and Dividends.&rdquo; Please see page 214 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Notes to the Consolidated Financial Statements for Arbe Robotics
LTD.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Note 3: Revenue, page F-15</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>17.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please revise to disclose the amount of revenue recognized in 2020 that was included in deferred revenue as of December 31,
2019. Refer to ASC 606-10-50-8(b).</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see page F-15 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>18.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please revise to separately disclose revenue from any individual foreign country, if material, or to state that no one country
generated a significant amount of revenue. Refer to ASC 280-10-50-41(a).</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see page F-15 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Note 7: Convertible Loan, page F-17</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>19.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note that the December 2020 convertible loan will convert into equity upon the occurrence of certain events, and that per
pro forma adjustment (H) it will convert as part of the merger transaction. Please revise to disclose the nature of these &quot;certain
events,&quot; including the fact that the loan will convert upon completion of this transaction.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Response</B>: The convertible note
referred to in Note 15a is the second installment of an investment made pursuant to an additional advance investment agreement which is
described in Note 7. Note 7 has been revised and describes the conversion events, one of which is an IPO, which includes a deSPAC transaction,
and refers to Note 15a. Please see pages F-18 and F-19.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Note 15. Subsequent Events, page F-26</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>20.</I></B></TD><TD STYLE="text-align: justify"><B><I>Revise to disclose the date that the financial statements were issued. Refer to ASC 855-10-50-1(a). Arbe / ITAC finance and
accounting teams to advise. Likely this will all be updated once Q1 information is provided.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company acknowledges
the Staff&rsquo;s comment and has revised the Registration Statement. Please see page F-29 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B><IMG SRC="img_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Eight</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Item 21. Exhibits and Financial Statement Schedules, page II-1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>21.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please file any material lease agreements and the employment agreements with your executive officers as exhibits to your registration
statement. Refer to Item 21 of Form F-4 and Item 601(b)(10) of Regulation S-K.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B>Response</B>: The Company does not believe
that its leases are material. The Company only rents office space pursuant to relatively short-term leases, the longest being for three
years. The Company believes that office space is readily available on reasonable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">The Company does not believe that the employment
agreements are required to be filed for the following reason:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Item 21 of Form F-4 cross refers to Item
601 of Regulation S-K. Regulation S-K 601(b)(10)(iii)(5) lists, as agreements that need not be filed &ldquo;Any compensatory plan, contract
or arrangement if the registrant is a foreign private issuer that furnishes compensatory information under Item 402(a)(1) (&sect; 229.402(a)(1))
and the public filing of the plan, contract or arrangement, or portion thereof, is not required in the registrant's home country and is
not otherwise publicly disclosed by the registrant.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Item 402(a)(1)
provides that a foreign private issuer will be deemed to comply with the executive compensation disclosure if it provides the
information required by Items 6.B and 6.E.2 of Form 20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Item 6.B reads as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">The amount of compensation paid, and benefits
in kind granted, to such persons by the company and its subsidiaries for services in all capacities to the company and its subsidiaries
by any person. Disclosure of compensation is required on an individual basis unless individual disclosure is not required in the company&rsquo;s
home country and is not otherwise publicly disclosed by the company. The standard also covers contingent or deferred compensation accrued
for the year, even if the compensation is payable at a later date. If any portion of the compensation was paid (a) pursuant to a bonus
or profit-sharing plan, provide a brief description of the plan and the basis upon which such persons participate in the plan; or (b)
in the form of stock options, provide the title and amount of securities covered by the options, the exercise price, the purchase price
(if any), and the expiration date of the options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Pursuant to Item 6.B, disclosure of compensation
on an individual basis is not required if it is not required by the issuer&rsquo;s home country and is not otherwise publicly disclosed.
Israeli laws do not require such disclosure and the Company does not otherwise disclose such information. The Company discloses aggregate
compensation under the heading &ldquo;Director and Executive Compensation &ndash; Aggregate Compensation to Directors and Officers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Item 6.E.2 relates to the disclosure of
arrangements involving the employees in the capital of the issuer. This information is included in the F-4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Since the Company meets the requirements
for exclusion set forth in Item 601(b)(10)(iii)(5), the Company does not believe that the employment agreements are required to be filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><IMG SRC="img_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.15in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 30, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page Nine</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify; text-indent: 0.5in">Any comments or questions regarding
the foregoing should be directed to the undersigned at 212-335-4651. Thank you in advance for your cooperation in connection with this
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jon Venick</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> JV:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cc: (via email)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jacob (Kobi) Marinka, Arbe Robotics Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Danny Klein, Arbe Robotics Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E. Scott Crist, Industrial Tech Acquisitions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Asher S. Levitsky, Ellenoff Grossman &amp; Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shay Dayan, Erdinast, Ben Nathan, Toledano &amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' '@# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[%_X*F?\
M!4?XP_%WXQ>._@A\$O'7B#X=? [X<Z_JW@J]NO!FK7>A:[\4=?T*\FTSQ#K&
ML:_I<UOJ2^$TU.VN[#0-!L;N"PU*QMQK&KK>RWUK::9^'TTTUQ++/<32W$\S
MM+-//*\T\TKDL\LTTK/)+([$L\DC,[$DL233KBXGN[BXN[F5Y[FZGFNKF>5B
M\L]Q<2--/-(QY:265WD=CRS,3WJ&O]E^#N#\BX(R+ 9%D6 PN$HX3"X>EB,1
M2H4H8K,<5"E36(QV.Q"IJOBL1B<0J]>4J]:JJ2JPHT84:-&G37^"?'O'G$?B
M)Q)F7$?$698S&UL9C,36PF%K8FM4PF58.I6JRPN79?A75>&PF&PF&=##J.'H
M4G6E2G7KSKUJ]2HRBO;/@%^SG\9_VGO'MM\-_@AX%U3QMXEE2.YU!K;9::'X
M;TQYEA;6O%6OW9CTO0-)CD.T7-].DMW*!::=;WMZ\=L_](W[/?\ P;T?#[3+
M"QU?]IWXN^(?%VN21)+=^"_A1Y?A?PM8S$*3:3^*]8L;[Q)KL:G*O<66G^%"
MQX1"H#MX/'/BSP)X>*-/B7.X4LPJ4U5HY/@*4\RS>I3E?DJ2P6&DGAJ-2S]G
M6QU?!TZB3=)5HIR7TGAUX)>)'BES5N%,@J5,KIU71K9[F=:&59)3J1:4Z<,=
MBH/ZY6IW_>4,OP^.J4W:-5T92C%_RFT5_>)HG_!';_@G/HEE'9_\,YZ;K#(
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M!YNZ7U+&XE9G+ZGA\/0J*IB:L*D::CR2M^Y%%?@AXK_X*<_MP?LN>*OAO?\
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
